Sold my position today to buy short time into CHTP. Be back in Jan to buy back in before the run up to Q4 numbers. Stay strong ya'll and hope the train doesn't leave without me!
That the best you got? I guess your just smarter than all the analysts that cover this stock. All hale Avi the Magnificent!
Wishful thinking on their part. GALE is going to trade in a range IMO somewhere between $3.90ish to $4.50 until mid/late Jan and then run up on expectation to the Q4 Abstral numbers.....my guess is to the $5.50/$6.00 area. What happens then will depend on the Abstral #'s.
My feeling is that you will see the short position continue to unwind as those that hedged their position with options eventually have to close out their position as the options expire. Naked shorts, if they haven't closed by now, would be well advised to close their positions by mid January as IMO, a run up will begin to take place in anticipation of Q4 Abstral revenue numbers. If they have the stones, they can try to short again just before the earnings release, but would highly suggest they do it with some hedged call options.
The poster is a poser. Not a original thought or scientific bone it it's body. Is easiest to just ignore the vial spawn spewing #$%$.
What WAS holding back institutions from buying GALE, was the fact that it WAS an all risk play. That all changed with the introduction of Abstral. Abstral is setting a floor for this stock to be valued at, which I believe will be in the $4-6 range which is giving institutions the GOLDEN opportunity to buy into GALE at this price point with little to no risk. For all you naysayers, just wait till the next posting of institutional ownership and you will see a significant increase.
Will NeuVax be successful? I don't know, and frankly, either do any of you bashers. But, for the sake of all cancer sufferers, I hope it is. From an investment point of view, I believe that at $4-5 this is a no brainer investment with the Abtstral support. Anything more than that, you are risking it on NeuVax's approval.
So, the question is, how much are you willing to risk?
I think to short this stock is the mother of all idiot plays at this level. If it runs up to $7 or $8 and you want to hedge with call options, then maybe you can make a few bucks, but naked shorts are nothing but weed induced fantasy.
Yo #$%$ #$%$.....why don't you go waste bits & bytes on some P*rn site where all the rest of the LOOSERS hang out
In your wet dreams pump-a-dump. Only way GALE hits $3, and I mean $3.00 and not $3.99 is if Q4 Abstral sales numbers are disappointing. This stock IMO will start a run in mid/late Jan to $5.50/$6 by the end of Feb. NeuVax is only adding maybe $2/share to this stock right now.
The next big catalyst besides Abstral quarterly numbers will be the mid term progress report on NeuVax, which if I remember Ahn saying will be out sometime in the later part of 2014. If this interim report is anywhere near promising, IMO, you will see a major deal struck for marketing rights in Europe.
As for NAZ.....you're just as bad as that fool Poly Sci major AF. Full of yourself. Who with any amount of believability even bothers to mention AH or PM numbers.
Not selling until it hits my price target to pull out my initial investment, then letting the rest ride. Only wish I had the funds to buy more on the dip!
I don't get my bonus until the end of the week.....was hoping to pick up a few more thousand shares below $4
Stay strong.....There will be NO bad news that will sink this stock within the next 3 months. You will see ups & downs, but expect pps in Feb to be in the area of $5.50 as anticipation builds for Abstral Q4 numbers. My opinion is you sell before the numbers and buy some call options
Gale will behave from Dec through Jan like INSYS did from March thru April. The question is, will Abstral numbers excite the market or disappoint when #'s are released in Feb for Q4?